FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
FTC sues drug middlemen over manipulating insulin market
The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
ConsumerAffairs35m
FTC alleges Caremark Rx, Express Scripts, Optum Rx inflated insulin prices
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
The Financial Times40m
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
The FTC, led by chair Lina Khan, is seeking to ultimately lower insurance premiums as well as wholesale prices, which in the case of Humalog, an Eli Lilly insulin drug, ballooned more than 1,200 per ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...